DELIVERY ORDER
ActiveHT942726FE073
Department of Defense › Defense Health Agency › DEFENSE HEALTH AGENCY
$187.7K
obligated · signed 4 months ago
PROGRAMMATIC REVIEW FOR PROSTATE CANCER RESEARCH PROGRAM (PCRP) FOR CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS (CDMRP).
Performance timeline
Start
Jul 1, 2026
End
Jun 30, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Jun 30, 2027
LEIDOS, INC.
Contract HT942726FE073
UEI
QLNMVC12KWY3
Parent Company
LEIDOS HOLDINGS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 11
Current Obligation
$187,702
Base + Exercised Options
$349,803
Total Ceiling Value
$349,803
Contract Type
COST PLUS FIXED FEE
Multi-Year Contract
NO
NAICS
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
PSC
SUPPORT- PROFESSIONAL: PROGRAM MANAGEMENT/SUPPORT
Place of Performance
Congressional District: 06
Awarding Agency
Funding Agency
Top-tier agency
Defense Health Agency
Sub-tier agency
CONG DIR MED RES PRGM / CDMRP - MM
Office
Contract Vehicle
HT942523D0002
IDCDepartment of Defense
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.